Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile

BACKGROUND: Irritable bowel syndrome is classified as a functional gastrointestinal disorder with the primary symptom of abdominal pain in conjunction with bloating and bowel movement disorder. It affects up to 15% of the world’s population. Among its subtypes, the most common is diarrhoea predomina...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Kamesh, Ghuman, Harparam Singh, Handa, Shivani Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582649/
https://www.ncbi.nlm.nih.gov/pubmed/28894393
http://dx.doi.org/10.1177/1179552217728905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582649/
https://www.ncbi.nlm.nih.gov/pubmed/28894393
http://dx.doi.org/10.1177/1179552217728905

Ejemplares similares